Advertisement Cambridge China Centre
Advertisement: Mogrify mid banner
Advertisement EY mid banner
Advertisement: Cambridge Network
RealVNC mid banner careers
Barr Ellison Solicitors – commercial property
Mid banner advertisement: BDO
RealVNC mid-banner general
Advertisement: RSM
Advertisement: TTP
Advertisement: Wild Knight Vodka
ARM Innovation Hub
Advertisement: Bradfield Centre mid
28 January, 2015 - 10:33 By News Desk

Targeted anti-cancer drug delivery system

Enterprise Europe Network TOSI20150107001

A Slovenian research institution has developed a molecular system for delivery of anti-cancer drugs specifically to target sites, by using cathepsin inhibitors as guides towards cathepsins released by tumour cells.

The system prevents toxic side effects, reduces the dosage, and treatment costs. The researchers seek investment, technical cooperation, and/or joint venture partnership, with partners with the capacity to fund and/or carry out pre-clinical studies and to scale up the production.

Closing date: 12/01/2016REF: TOSI20150107001

Add new comment

Newsletter Subscription

Stay informed of the latest news and features